Ichthyosis Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Funding
• Clinical Trials

The Efficacy and Safety of Secukinumab in Patients With Ichthyoses
Conditions:   Ichthyosis;   Autosomal Recessive Congenital Ichthyosis;   Lamellar Ichthyosis;   Congenital Ichthyosiform Erythroderma;   Epidermolytic Ichthyosis;   Netherton Syndrome Interventions:   Drug: Secukinumab;   Drug: Placebo Sponsors:   Northwestern University;   Novartis;   Icahn School of Medicine at Mount Sinai Recruiting - verified January 2017 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 17, 2017 Category: Research Source Type: clinical trials